Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

1,231 public trials 93 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

NCT06431763

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Stuttgart, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Lichtenfels, Bavaria, Germany
  • Novartis Investigative Site Muehldorf Am Inn, Bavaria, Germany
View all 55 locations
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

NCT04659863

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia - Homozygous, +10 more
Locations
  • Excel Medical Clinical Trials LLC Boca Raton, Florida, United States
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Bron, France
  • University General Hospital of Ioannina Ioannina, GR, Greece
View Trial Details
Completed

A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

NCT06555640

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Baoding No.1 Central Hospital Baoding, China
  • The First Affiliated Hospital of Baotou Medical College Baotou, China
  • Peking University First Hospital Beijing, China
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, China
View all 35 locations
View Trial Details
Completed

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

NCT05888103

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +12 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Zhongshan, Guangdong, China
View all 28 locations
View Trial Details
Completed

Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Patients With Familial Hypercholesterolemia

NCT05695937

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations
  • Hospital São José Criciúma, Brazil
  • Hospital das Clínicas da Universidade Federal de Goiás Goiânia, Brazil
  • Universidade Regional do Noroeste do Estado do Rio Grande do Sul Ijuí, Brazil
  • Instituto Nacional de Cardiologia Rio de Janeiro, Brazil
View Trial Details
Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

NCT03747224

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 1 Nedlands, Australia
  • Research Site 4 Grafton, Auckland, New Zealand
View Trial Details
Completed

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

NCT03783377

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 5 Sippy Downs, Queensland, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 4 Perth, Washington, Australia
View Trial Details

Related conditions